We specialize in hard to find items
(1)
Cures Vs. Profits: Successes In Translational Research
Share Tweet
*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
- Electrical items MAY be 110 volts.
- 7 Day Return Policy
- All products are genuine and original
- Cash On Delivery/Cash Upon Pickup Available
About Cures Vs. Profits: Successes In Translational
Did you ever wonder whether doctors want cures, or just treatments? Did you know ... Grapefruit can interact with over 100 drugs, but it may be useful for reducing blood pressure and for weight loss? ADHD over diagnosis is now recognized widely as a fact, and there are existing -- and new ways -- to avoid a misdiagnosis? Studies have been conducted demonstrating the utility of Omega 3 fatty acids, meditation, yoga, and melatonin for some important symptoms of ADHD, including executive functions? Vaccines have saved millions of lives in the last decade? But are the safe? Breast cancer rates are declining in the US, but have been steadily increasing in Japan? Doctors are getting better at predicting which chemotherapy will, and will not work, on certain cancers? There are vaccines against cancer? This book reviews recent key, hard-won successes and findings from recent biomedical research. Written by one of the most ardent defenders of the public trust in science, it provides an accessible, detailed look at successes in translational biomedical and clinical research. The author provides an optimistic, forward-looking view for the possibility of change for the public good, cutting through the controversy and gets to very core of each topic. The public can be optimistic about the future of medicine, but only if they learn the facts of these advances, and learn what their doctors should be expected to know. Highly referenced, and filled with interviews from experts and people directly involved in the research behind the new facts in each chapter, this book is a rich source of information on advances in biomedicine that you will want to share with your family & friends. Readership: Lay public, scientists, doctors, politicians, policy makers, public health workers, health care worker, investors.
